J-GLOBAL ID:202001015314841372   Update date: Oct. 26, 2021

Moriyama Takahito

モリヤマ タカヒト | Moriyama Takahito
Affiliation and department:
Job title: Associate Professor
Research field  (1): Nephrology
Research keywords  (4): エンドサイトーシス ,  糸球体内皮細胞 ,  カベオラ ,  IgA腎症
Papers (103):
  • Takahito Moriyama, Hiroshi Kataoka, Kosaku Nitta, Keita Hirano, Keiichi Matsuzaki, Takashi Yasuda, Yoshinari Yasuda, Kentaro Koike, Shoichi Maruyama, Takashi Yokoo, et al. Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan. Clinical and Experimental Nephrology. 2020. 25. 1. online-27
  • Takahito Moriyama, Kazunori Karasawa, Yoei Miyabe, Kenichi Akiyama, Yuko Iwabuchi, Shota Ogura, Tomo Takabe, Naoko Sugiura, Momoko Seki, Norio Hanafusa, et al. Long-term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A Nephropathy. Kidney360. 2020
  • Moriyama Takahito, Karasawa Kazunori, Miyabe Yoei, Akiyama Kenichi, Ogura Shota, Takabe Tomo, Sugiura Naoko, Seki Momoko, Iwabuchi Yuko, Uchida Keiko, et al. Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors. Scientific Reports. 2020. 10:11151
  • Moriyama Takahito, Nitta Kosaku. Secondary Publication: Clinical Grade of IgA Nephropathy. TWMUJ. 2020. 1-8
  • Kumon Saeko, Moriyama Takahito, Kamiyama Takahiro, Karasawa Kazunori, Nitta Kosaku. The impact of tonsillectomy combined with steroid pulse therapy in patients with advanced IgA nephropathy and impared renal function. Clinical and Experimental Nephrology. 2020. 24. 295-306
MISC (8):
  • 森山 能仁. 【いま知っておきたい! 内科最新トピックス】(第11章)腎・尿路系 慢性糸球体腎炎におけるrituximab 使い方のコツとメリット. 内科. 2020. 126. 3. 631-634
  • Secondary Publication: Clinical Grade of IgA Nephropathy. 2020. online
  • Clinical and histological features and therapeutic strategies for IgA nephropathy. 2019. 23. 1089-1099
  • 森山能仁, 新田孝作. 【IgA腎症-診断・治療の最新動向-】IgA腎症の診断学 臨床検査的重症度分類. 日本臨床. 2019. 77. 4. 643-650
  • 岩渕裕子, 唐澤一徳, 森山能仁, 新田孝作. 【ネフローゼ症候群-MCNS/FSGSの最新知見】治療のエビデンスとその構築 成人ネフローゼ症候群 生物学的製剤(リツキシマブ)の使い方. 腎と透析. 2018. 85. 6. 823-827
Books (8):
  • 「IgA 腎症の基礎と臨床」
    中外医薬社 2019
  • むかしの頭で診ていませんか?腎臓・高血圧診療をスッキリまとめました
  • 研修医のための腎臓内科病棟マニュアル「研修医のための腎臓内科病棟マニュアル」
    東京医学社 2018
  • 「IgA腎症の臨床」
    東京医学社 2018
  • 「腎疾患・透析 最新の治療2017-2019」
    南江堂 2017
Lectures and oral presentations  (151):
  • Intracellular trafficking pathway of albumin in glomerular epithelial cells
    (ASN Kidney Week 2019 2019)
  • Study of long term recurrence and adverse effects of rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome
    (ASN Kidney Week 2019 2019)
  • Analysis of appropriate treatment for IgA nephropathy with mild proteinuria
    (ASN Kidney Week 2019 2019)
  • Analysis of 40-year prognosis of 1149 cases of IgA nephropathy and validation study of Oxford classification
    (ASN Kidney Week 2019 2019)
  • The Deposition of Immunoglobulin A on the Glomerular Loop Correlates with Severity Both Clinically and Pathologically in a Patient with IgA Vasculitis with Nephritis
    (ASN Kidney Week 2019 2019)
Education (1):
  • 1992 - 1998 Tokyo Medical University
Professional career (1):
  • 医学博士 (東京医科大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page